Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Capsule Opacification

• Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
• A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery
• Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
• Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
• Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
• Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
• Cognitive Dysfunction After Cataract Surgery
• Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
• A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
• Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery
• Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery
• Bromfenac Versus Dexamethasone After Cataract Surgery
• Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery
• Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
• A 8 Weeks Study to Evaluate Efficacy & Safety of rhNGF vs Vehicle in Patients After Cataract and Refractive Surgery
• Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery
• OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery
• Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery
• OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery
• PRevention of Macular EDema After Cataract Surgery
• The Effect of Intravitreal Ozurdex on DME After Cataract Surgery
• A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
• Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
• Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus
• Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery
• Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)
• Intraocular Steroid After Cataract Surgery Study
• Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery
• Effect of Prophylactic Ketorolac on CME After Cataract Surgery
• Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery
• A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery